Browsing by Author "Tsimourtou, Vana"
Now showing items 1-3 of 3
-
Article
Autoimmune hepatitis in patients with multiple sclerosis: The role of immunomodulatory treatment
Rigopoulou, Eirini I.; Gyftaki, Sofia; Arvaniti, Pinelopi; Tsimourtou, Vana; Koukoulis, George K.; Hadjigeorgiou, Georgios; Dalekos, George N. (2019)BACKGROUND: Development of autoimmune hepatitis (AIH) has been sporadically reported in patients with multiple sclerosis (MS) either concurrently or after treatment with immunomodulatory drugs, including interferon-beta ...
-
Article
Regulatory B and T lymphocytes in multiple sclerosis: friends or foes?
Vasileiadis, Georgios K.; Dardiotis, Efthymios; Mavropoulos, Athanasios; Tsouris, Zisis; Tsimourtou, Vana; Bogdanos, Dimitrios P.; Sakkas, Lazaros I.; Hadjigeorgiou, Georgios M. (2018)Current clinical experience with immunomodulatory agents and monoclonal antibodies in principle has established the benefit of depleting lymphocytic populations in relapsing–remitting multiple sclerosis (RRMS). B and T ...
-
Article
Replication study of GWAS risk loci in Greek multiple sclerosis patients
Hadjigeorgiou, Georgios M.; Kountra, Persia-Maria; Koutsis, Georgios; Tsimourtou, Vana; Siokas, Vasileios; Dardioti, Maria; Rikos, Dimitrios; Marogianni, Chrysoula; Aloizou, Athina-Maria; Karadima, Georgia; Ralli, Styliani; Grigoriadis, Nikolaos; Bogdanos, Dimitrios; Panas, Marios; Dardiotis, Efthimios (2019)To validate in an ethnically homogeneous Greek multiple sclerosis (MS) cohort, genetic risk factors for the disease, identified through a number of previous multi-ethnic genome-wide association studies (GWAS).